Ethanol injection of prostate

Alexander C. Small, Michael A. Palese

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Ethanol injection for chemoablation of the prostate for the treatment of benign prostatic hyperplasia is a concept first described in the early 1900s and one that garnered considerable excitement in the last 15 years. Dehydrated ethanol delivered via transperineal, transurethral, or transrectal approaches can have severe pathologic effects on prostate tissue and serves to atrophy the gland. However, injections result in highly uneven lesions and extraprostatic leakage can have devastating consequences. Studies initially showed promising results, but variable outcomes and lack of standard techniques have hindered the widespread adoption of ethanol ablation. Common adverse effects included dysuria, urinary retention, and hematuria, and rare cases of bladder necrosis have been reported. In this chapter, we will review the techniques and evidence for this approach.

Original languageEnglish (US)
Title of host publicationTreatment of Benign Prostatic Hyperplasia
Subtitle of host publicationModern Alternative to Transurethral Resection of the Prostate
PublisherSpringer New York
Pages163-172
Number of pages10
ISBN (Electronic)9781493915873
ISBN (Print)9781493915866
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Ethanol injection of prostate'. Together they form a unique fingerprint.

Cite this